Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Mozobil for Autologous Stem Cell Mobilization [Phase 2]
Phase 2 trial update for Mozobil (plerixafor) assessing autologous stem cell mobilization has completed in Non-Hodgkin's Lymphoma and Hodgki…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies [Phase 1]
Phase 1 safety study of carfilzomib (PR-171) in hematologic malignancies has completed and results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of lenalidomide plus rituximab as maintenance therapy for adult B-cell non-Hodgkin lymphoma is noted as terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: A Study Of Panobinostat In Children With Refractory Hematologic Malignancies [Phase 1]
This update reports the completion of a Phase 1 pediatric study evaluating panobinostat in children with refractory hematologic malignancies…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Study of Repeat Intranodal Injections of Ad-ISF35 [Phase 2]
Phase 2 study of repeat intranodal injections of Ad-ISF35 in various non-Hodgkin lymphomas was terminated; results were posted in 2015.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-11-20Clinical Trial Update: Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors [NA]
This trial evaluating dietary and exercise interventions to prevent cardiovascular disease in young survivors of childhood cancers (brain tu…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma [Phase 1]
A Phase 1 clinical trial of a vaccine therapy for patients with recurrent B-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating a triple regimen of vorinostat, tacrolimus, and methotrexate to prevent graft-versus-host disease after allogeneic …
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab
This trial update summarizes results for patients with low-grade non-Hodgkin lymphoma who were previously treated with Tositumomab and/or io…
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer [Phase 1]
Pfizer's Phase 1 study of the CDK4/6 inhibitor palbociclib in patients with advanced cancer, including Non-Hodgkin lymphoma, has completed a…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
This clinical trial update reports Phase 2 results for radioimmunotherapy in patients with relapsed or refractory non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment [Phase 2]
Phase 2 study evaluating YM155 in combination with Rituximab in patients with previously treated Non-Hodgkin's Lymphoma; the trial status is…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
This clinical trial update reports the long-term effects of combining Iodine-131 labeled tositumomab with autologous bone marrow or stem cel…
-
CLINICAL_TRIALS withdrawal · 2015-10-12Clinical Trial Update: Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas [Phase 2]
This clinical trial update notes that the Phase 2 study of the anti-CD20 antibody ofatumumab in older patients with untreated indolent B-cel…
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL) [Phase 3]
Phase 3 trial of Galiximab plus Rituximab versus Rituximab plus placebo in follicular non-Hodgkin's lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit [Phase 2]
Phase 2 clinical trial evaluating hematopoietic stem cell transplantation using a CD34-selected mismatched related donor plus one umbilical …
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial of rituximab in young patients receiving chemotherapy for B-cell non-Hodgkin lymphoma or B-cell acute lymphoblastic leukemia h…
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN) [Phase 1, Phase 2]
This is a dose-escalating Phase 1/2 trial evaluating obinutuzumab in CD20+ malignant diseases (lymphoma). The study has completed and result…
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 1]
Phase 1 study of Vinorelbine Liposome Injection for advanced solid tumors, Hodgkin lymphoma, and Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 pilot trial evaluating radiation-enhanced allogeneic cell therapy for progressive hematologic malignancies after allogeneic stem cel…
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155 [Phase 2]
Extension phase 2 study update for YM-155 in prostate cancer, melanoma, and non-Hodgkin lymphoma; status completed.
-
CLINICAL_TRIALS withdrawal · 2015-08-19Clinical Trial Update: Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating rituximab with dexamethasone for recurrent or refractory indolent non-Hodgkin lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-19Clinical Trial Update: Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating Rituxan (Rituximab) plus Cytoxan (cyclophosphamide) for indolent stage III or stage IV non-Hodgkin lymphoma has b…
-
CLINICAL_TRIALS research · 2015-08-13Clinical Trial Update: Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant [EARLY_Phase 1]
Early-phase 1 trial evaluating dose monitoring of busulfan in conditioning regimens with combination chemotherapy for Hodgkin lymphoma or No…
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial results evaluating chemotherapy with or without total-body irradiation followed by stem cell transplant in patients with Non-H…